Novo Nordisk

Reconstruction of Novo Nordisk insulin preparations plant.
Kaluga Region, Kaluga, Industrial Park Grabtsevo, 2016-2017

Within the framework of the enterprise reconstruction project, a new production building was constructed and the input group of the plant was reconstructed for one of the world leaders in the development and production of drugs for the treatment of diabetes mellitus, the global pharmaceutical company Novo Nordisk (headquartered in Denmark).
The newly built production building for the production of a high-tech pharmaceutical product - FlexPen® handles with office space on the second floor of the building-extension to the main building of the plant with a total area of ​​1900 m2.
Attachment of the main entrance with partial integration with the existing premises of the plant with a total area of ​​300 m2 with the arrangement of the entrance group and a global reconstruction of the existing landscaping of the plant territory.